Knowledge levels of oncology nurses regarding evidence-based practices in the assessment and management of chemotherapy-induced peripheral neuropathy

Basit Öğe Kaydı
dc.authoridCelik, Aysegul/0000-0003-1786-0309
dc.contributor.authorCelik, Aysegul
dc.contributor.authorYesilbalkan, Oznur Usta
dc.date.accessioned2025-03-20T09:51:13Z
dc.date.available2025-03-20T09:51:13Z
dc.date.issued2024
dc.departmentİzmir Bakırçay Üniversitesi
dc.description.abstractObjective: The study aimed to determine the level of oncology nurses' knowledge of evidence-based practice for assessing and managing chemotherapy-induced peripheral neuropathy (CIPN). Methods: This study employed a descriptive and cross-sectional research design. It was carried out with oncology nurses who were working at a university hospital in the Western Region of Turkey and who were members of the Oncology Nursing Association. The sample of the study consisted of 96 nurses who met the inclusion criteria. Results: The study sample comprised 94.8% female oncology nurses, 57.3% of whom held an undergraduate degree, and over half (58.5%) of whom were employed as clinical nurses. A majority of nurses (76.0%) indicated that they had not received any training in peripheral neuropathy. 35.4% of the nurses assessed patients receiving neurotoxic chemotherapy for peripheral neuropathy at each visit/each chemotherapy cycle. A total of 43.8% of nurses indicated that they frequently assessed patients for peripheral neuropathy at the conclusion of the treatment protocol. The oncology nurses assessed the patient-reported symptoms of motor neuropathy (58.3%), sensory neuropathy (56.3%), autonomic neuropathy (51.0%), neuropathic pain (55.2%), and co-occurring symptoms (52.1%) on a frequent basis. The nurses reported that they assessed muscle strength (56.3%), gait and balance (58.3%), and quality of life (52.1%) frequently. In contrast, they assessed deep tendon reflex (41.7%), neurological tests (36.5%), and social activities (46.8%) rarely. Conclusions: The study findings indicated that oncology nurses require further education and training in evidencebased practices for the assessment and management of CIPN.
dc.identifier.doi10.1016/j.apjon.2024.100581
dc.identifier.issn2347-5625
dc.identifier.issn2349-6673
dc.identifier.issue10
dc.identifier.pmid39310727
dc.identifier.scopus2-s2.0-85203549908
dc.identifier.scopusqualityQ3
dc.identifier.urihttps://doi.org/10.1016/j.apjon.2024.100581
dc.identifier.urihttps://hdl.handle.net/20.500.14034/2471
dc.identifier.volume11
dc.identifier.wosWOS:001315355600001
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier Science Inc
dc.relation.ispartofAsia-Pacific Journal of Oncology Nursing
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250319
dc.subjectOncology nursing
dc.subjectEvidence-based practice
dc.subjectChemotherapy-induced peripheral neuropathy
dc.subject(CIPN)
dc.subjectPatient care management
dc.titleKnowledge levels of oncology nurses regarding evidence-based practices in the assessment and management of chemotherapy-induced peripheral neuropathy
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu